BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 17276525)

  • 21. Characterization of a kallidin receptor in the eel intestine.
    Cougnon N; Deacon CF; Lilley KS; Henderson IW
    Agents Actions Suppl; 1992; 38 ( Pt 2)():382-9. PubMed ID: 1334338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of bradykinin receptors in a human osteoblastic cell line.
    Brechter AB; Lerner UH
    Regul Pept; 2002 Jan; 103(1):39-51. PubMed ID: 11738247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human non-pigmented ciliary epithelium bradykinin B2-receptors: receptor localization, pharmacological characterization of intracellular Ca(2+) mobilization, and prostaglandin secretion.
    Sharif NA; Wang Y; Katoli P; Xu S; Kelly CR; Li L
    Curr Eye Res; 2014 Apr; 39(4):378-89. PubMed ID: 24624903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of bradykinin receptors in guinea pig gall bladder.
    Falcone RC; Hubbs SJ; Vanderloo JD; Prosser JC; Little J; Gomes B; Aharony D; Krell RD
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1291-9. PubMed ID: 8396632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. B-9972 (D-Arg-[Hyp3,Igl5,Oic7,Igl8]-bradykinin) is an inactivation-resistant agonist of the bradykinin B2 receptor derived from the peptide antagonist B-9430 (D-Arg-[Hyp3,Igl5,D-Igl7,Oic8]-bradykinin): pharmacologic profile and effective induction of receptor degradation.
    Bawolak MT; Gera L; Morissette G; Stewart JM; Marceau F
    J Pharmacol Exp Ther; 2007 Nov; 323(2):534-46. PubMed ID: 17699739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of Ca2+-sensitization in attenuated carbachol-induced contraction of the colon in a rat model of colitis.
    Al-Jarallah A; Khan I; Oriowo MA
    Eur J Pharmacol; 2008 Jan; 579(1-3):365-73. PubMed ID: 18037403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of kinin receptors in human cultured detrusor smooth muscle cells.
    Bellucci F; Cucchi P; Santicioli P; Lazzeri M; Turini D; Meini S
    Br J Pharmacol; 2007 Jan; 150(2):192-9. PubMed ID: 17179953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The N-terminal of icatibant and bradykinin interact with the same Asp residues in the human B2 receptor.
    Bellucci F; Meini S; Cucchi P; Catalani C; Giuliani S; Zappitelli S; Rotondaro L; Quartara L; Giolitti A; Maggi CA
    Eur J Pharmacol; 2004 May; 491(2-3):121-5. PubMed ID: 15140628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of sympathetic N-type voltage-gated Ca2+ current underlies the reduction in norepinephrine release during colitis.
    Motagally MA; Neshat S; Lomax AE
    Am J Physiol Gastrointest Liver Physiol; 2009 May; 296(5):G1077-84. PubMed ID: 19264956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MEN16132, a novel potent and selective nonpeptide kinin B2 receptor antagonist: in vivo activity on bradykinin-induced bronchoconstriction and nasal mucosa microvascular leakage in anesthetized guinea pigs.
    Valenti C; Cialdai C; Giuliani S; Lecci A; Tramontana M; Meini S; Quartara L; Maggi CA
    J Pharmacol Exp Ther; 2005 Nov; 315(2):616-23. PubMed ID: 16027229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peripheral kinin B(1) and B(2) receptor-operated mechanisms are implicated in neuropathic nociception induced by spinal nerve ligation in rats.
    Werner MF; Kassuya CA; Ferreira J; Zampronio AR; Calixto JB; Rae GA
    Neuropharmacology; 2007 Jul; 53(1):48-57. PubMed ID: 17555775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neutral endopeptidase up-regulation in isolated human umbilical artery: involvement in desensitization of bradykinin-induced vasoconstrictor effects.
    Pelorosso FG; Halperin AV; Palma AM; Nowak W; Errasti AE; Rothlin RP
    J Pharmacol Exp Ther; 2007 Feb; 320(2):713-20. PubMed ID: 17085545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The bradykinin B2 receptor antagonist icatibant (Hoe 140) blocks aminopeptidase N at micromolar concentrations: off-target alterations of signaling mediated by the bradykinin B1 and angiotensin receptors.
    Bawolak MT; Fortin JP; Vogel LK; Adam A; Marceau F
    Eur J Pharmacol; 2006 Dec; 551(1-3):108-11. PubMed ID: 17026984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BK2 but not BK1 receptors mediating contractile response in human umbilical arteries: role of thromboxane A2.
    Tiritilli A; El Habach T; Haury L; Duret JF
    Methods Find Exp Clin Pharmacol; 2004 May; 26(4):247-52. PubMed ID: 15319801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sensitization to bradykinin B1 and B2 receptor activation in UV-B irradiated human skin.
    Eisenbarth H; Rukwied R; Petersen M; Schmelz M
    Pain; 2004 Jul; 110(1-2):197-204. PubMed ID: 15275768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological characterization of canine bradykinin receptors in prostatic culture and in isolated prostate.
    Srinivasan D; Burbach LR; Daniels DV; Ford AP; Bhattacharya A
    Br J Pharmacol; 2004 May; 142(2):297-304. PubMed ID: 15155537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression and functional pharmacology of the bradykinin B1 receptor in the normal and inflamed human gallbladder.
    Andre E; Gazzieri D; Bardella E; Ferreira J; Mori MA; Saul VV; Bader M; Calixto JB; De Giorgio R; Corinaldesi R; Geppetti P; Trevisani M
    Gut; 2008 May; 57(5):628-33. PubMed ID: 18182589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-affinity binding of peptide agonists to the human B1 bradykinin receptor depends on interaction between the peptide N-terminal L-lysine and the fourth extracellular domain of the receptor.
    Fathy DB; Kyle DJ; Leeb-Lundberg LM
    Mol Pharmacol; 2000 Jan; 57(1):171-9. PubMed ID: 10617692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological, pharmacokinetic, and primate analgesic efficacy profile of the novel bradykinin B1 Receptor antagonist ELN441958.
    Hawkinson JE; Szoke BG; Garofalo AW; Hom DS; Zhang H; Dreyer M; Fukuda JY; Chen L; Samant B; Simmonds S; Zeitz KP; Wadsworth A; Liao A; Chavez RA; Zmolek W; Ruslim L; Bova MP; Holcomb R; Butelman ER; Ko MC; Malmberg AB
    J Pharmacol Exp Ther; 2007 Aug; 322(2):619-30. PubMed ID: 17470643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid modulation of micro-opioid receptor signaling in primary sensory neurons.
    Berg KA; Patwardhan AM; Sanchez TA; Silva YM; Hargreaves KM; Clarke WP
    J Pharmacol Exp Ther; 2007 Jun; 321(3):839-47. PubMed ID: 17347322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.